CAR T-cell therapy is a game changing cancer treatment that uses a patient’s own immune system to battle blood cancers like leukemia and lymphoma. By genetically modifying T cells to target cancer specific antigens, this treatment has shown remarkable success in treating refractory cancers.
What Is Car T-Cell Therapy?
CAR T-cell therapy is an advanced immunotherapy used to treat certain blood cancers like leukemia and lymphoma. It works by modifying a patient’s own T cells, a type of white blood cell, to recognize and attack cancer cells better. The process begins with extracting T cells from the patient’s blood. These cells are then genetically engineered in a lab to express a special receptor called a chimeric antigen receptor (CAR) which targets cancer cell antigens. After modification, the cells are multiplied and infused back into the patient’s bloodstream. Once in the body, CAR T cells bind to cancer cells and trigger an immune response to destroy them. This treatment has shown great success in treating refractory cancers but may cause severe side effects like cytokine release syndrome and neurological problems.
India: A Leading Destination for CAR T-Cell Therapy
CAR T-cell therapy is a game changer for cancer patients, a new way to fight blood cancers. Many patients look for quality treatment that is effective and affordable. India is the top destination for CAR T-cell therapy, world class treatment at a fraction of the cost compared to western countries. The affordability along with good infrastructure and expert doctors makes India the preferred choice for international patients. Compared to Australia where CAR T-Cell therapy costs around $350,000, India offers the same treatment for around $55,000 so patients can get cutting edge treatment without any financial burden.
Why India for CAR T-Cell Therapy?
India is not just known for its cost effective treatment but also for its well trained doctors and good infrastructure. Many Indian doctors have training and certifications from top global institutions so they are well equipped with latest advancements in CAR T-cell therapy. Hospitals like Artemis Hospital (Gurgaon), Fortis Hospital or Manipal Hospitals (Dwarka) have state of the art technology and personalized care for each patient. This personalized approach gives better treatment outcomes and smooth recovery. India’s focus on medical innovation and collaboration with international experts makes it a global leader in CAR T-cell therapy.
Various Forms of CAR T-Cell Therapy
Following are the various forms of CAR T-cell therapy:
- Tisagenlecleucel (Kymriah)
This treatment is applied for B-cell acute lymphoblastic leukaemia (ALL) in children and young adults up to 25 years and some forms of large B-cell lymphoma in adults. It is done by engineering the patient's T cells to attack the CD19 antigen on cancer cells. This treatment is priced from $48,100 to $90,100 in India and from $200,500 to $312,500 in Australia.
- Axicabtagene Ciloleucel (Yescarta)
It is approved to treat some forms of large B-cell lymphoma in adults, and it also attacks the CD19 antigen. It's really effective in people who didn't respond well to other treatments before. In India the therapy runs from $45,500 to $85,500, while in Australia the price is from $250,000 to $343,750.
- Brexucabtagene Autoleucel (Tecartus)
It is applied in adults who have received no response from any other treatment for mantle cell lymphoma. It targets the CD19 antigen and results from trials look very promising. The cost of this therapy is from $40,300 to $88,000 in India and from $190,000 to $325,000 in Australia.
- Lisocabtagene Maraleucel (Breyanzi)
Indicated for the treatment of some forms of large B-cell lymphoma in adults, this treatment also involves targeting the CD19 antigen. It provides an individualized treatment for cancer using the patient's own T cells. This treatment is priced from $50,000 to $78,000 in India and from $210,500 to $331,250 in Australia.
- Idecabtagene Vicleucel (Abecma)
This treatment is used to treat patients whose multiple myeloma has not responded to other treatments already used. It targets the BCMA antigen present on cancer cells. This treatment is priced from $52,600 to $96,000 in India and from $220,500 to $337,500 in Australia.
- Ciltacabtagene Autoleucel (Carvykti)
This therapy is approved for treating a severe condition known as multiple myeloma and also targets that antigen known as BCMA. It has proved to be extremely effective in clinical trials, giving new hope to patients with this difficult cancer. This treatment is priced from $50,000 to $91,000 in India and from $280,000 to $343,750 in Australia.
- Obecabtagene Autoleucel (Aucatzyl)
This therapy is still under investigation but has shown promise in targeting various antigens on cancer cells. It symbolizes a new generation of CAR T cell therapies that aim high in effectiveness and are better at minimizing side effects too. This therapy costs from $55,000 to $80,000 in India and from $300,000 to $350,000 in Australia.
Price comparison table of the various types of CAR T-cell therapy Australia and in India:
|
CAR T-Cell Therapy Type |
India |
Australia |
|
Tisagenlecleucel (Kymriah) |
From $48,100 to $90,100 |
From $200,500 to $312,500 |
|
Axicabtagene Ciloleucel (Yescarta) |
From $45,500 to $85,500 |
From $250,000 to $343,750 |
|
Brexucabtagene Autoleucel (Tecartus) |
From $40,300 to $88,000 |
From $190,000 to $325,000 |
|
Lisocabtagene Maraleucel (Breyanzi) |
From $50,000 to $78,000 |
From $210,500 to $331,250 |
|
Idecabtagene Vicleucel (Abecma) |
From $52,600 to $96,000 |
From $220,500 to $337,500 |
|
Ciltacabtagene Autoleucel (Carvykti) |
From $50,000 to $91,000 |
From $280,000 to $343,750 |
|
Obecabtagene Autoleucel (Aucatzyl) |
From $55,000 to $80,000 |
From $300,000 to $350,000 |
Racure Healthcare: Your Reliable Partner for Medical and Travel Assistance in India
We at Racure Healthcare offer end-to-end support to patients who require CAR T-cell therapy in India. With smooth medical coordination and expert advice, we make the treatment process easy. Our services cover customized medical suggestions, specialist consultations with in-house experts, and virtual pre-travel tele-consultations to get patients ready before they arrive. Patients have access to a handpicked list of leading hospitals and doctors while enjoying priority scheduling for immediate and efficient care. Post-operative care is also offered to help ensure a quick recovery process.
Besides medical assistance, we provide comprehensive travel assistance such as visa facilitation, online visa application consultation, and assistance with flight booking. Free airport transfers ensure a hassle-free arrival and departure. We also offer logistical assistance like accommodation advice, arrival SIM cards, interpretation services, and coordination for extending visas if necessary. Our specific 24/7 patient care team ensures complete satisfaction of needs during the visit. Easy currency exchange facilities are also provided for financial convenience. With Racure Healthcare, patients can have faith in opting for India for CAR T-cell therapy because they will be given the best treatment, expert medical advice, and hassle-free travel assistance.
